Handelen Edwards Lifesciences - EW CFD

Established in 1958, Edwards Lifesciences (EW)is an acknowledged leader in production of technologies for heart disease treatment. The company’s headquarters are based in Irvine, California. Apart from heart valve treatment, the company specialises in vascular therapy, surgical monitoring, critical care services. Edwards Lifesciences employs 12,000 people worldwide. The company’s shares are quoted on the New York Stock Exchange (NYSE). To stay updated on the latest Edwards Lifesciences share price, follow Capital.com.